Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suraj Venna

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of the American Academy of Dermatology|November 30, 2020
Five-year survival in patients with nodular and superficial spreading melanomas in the US populationBlair S Allais, Meghan Beatson, Hongkun Wang, et al.
Journal of Cutaneous Pathology|September 21, 2010
Recurrent erythema multiforme triggered by progesterone sensitivityTeresa J Nasabzadeh, Catherine M Stefanato, John E Doole, et al.
Archives of Dermatology|September 13, 2002
Should the skin cancer examination be taught in medical school?Alan C Geller, Suraj Venna, Marianne Prout, et al.
Journal of the American Academy of Dermatology|April 9, 2020
Importance of pathology review to complement clinical management of melanomaMeghan Beatson, Misty G Eleryan, Jeave Reserva, et al.
JCO Oncology Practice|February 20, 2026
Same-Day Multidisciplinary Clinics for Patients With Newly Diagnosed Adult Solid Tumor Cancer: A Systematic ReviewJohn F Deeken, Wayne Pereanu, Raymond C Wadlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
A multimarker prognostic assay for primary cutaneous melanomaMohammed Kashani-Sabet, Suraj Venna, Mehdi Nosrati, et al.
Journal of the American Academy of Dermatology|October 15, 2025
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse featuresWesley Y Yu, Ani Pazhava, Marie B Weitemeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2012
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasisDavid De Semir, Mehdi Nosrati, Vladimir Bezrookove, et al.
Journal of the American Academy of Dermatology|June 23, 2022
Delays in melanoma presentation during the COVID-19 pandemic: A nationwide multi-institutional cohort studyNicole Trepanowski, Michael S Chang, Guohai Zhou, et al.
JAMA Dermatology|March 15, 2023
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile TestingMohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of the American Academy of Dermatology|November 30, 2020
Five-year survival in patients with nodular and superficial spreading melanomas in the US populationBlair S Allais, Meghan Beatson, Hongkun Wang, et al.
Journal of Cutaneous Pathology|September 21, 2010
Recurrent erythema multiforme triggered by progesterone sensitivityTeresa J Nasabzadeh, Catherine M Stefanato, John E Doole, et al.
Archives of Dermatology|September 13, 2002
Should the skin cancer examination be taught in medical school?Alan C Geller, Suraj Venna, Marianne Prout, et al.
Journal of the American Academy of Dermatology|April 9, 2020
Importance of pathology review to complement clinical management of melanomaMeghan Beatson, Misty G Eleryan, Jeave Reserva, et al.
JCO Oncology Practice|February 20, 2026
Same-Day Multidisciplinary Clinics for Patients With Newly Diagnosed Adult Solid Tumor Cancer: A Systematic ReviewJohn F Deeken, Wayne Pereanu, Raymond C Wadlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
A multimarker prognostic assay for primary cutaneous melanomaMohammed Kashani-Sabet, Suraj Venna, Mehdi Nosrati, et al.
Journal of the American Academy of Dermatology|October 15, 2025
CP-GEP identifies high-risk T1a melanoma patients beyond established adverse featuresWesley Y Yu, Ani Pazhava, Marie B Weitemeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2012
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasisDavid De Semir, Mehdi Nosrati, Vladimir Bezrookove, et al.
Journal of the American Academy of Dermatology|June 23, 2022
Delays in melanoma presentation during the COVID-19 pandemic: A nationwide multi-institutional cohort studyNicole Trepanowski, Michael S Chang, Guohai Zhou, et al.
JAMA Dermatology|March 15, 2023
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile TestingMohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, et al.
Pageof 2